COVID and Emerging Diseases Funding

Due to the rapidly evolving pandemic funding opportunities will be added as they are received.  Monitor this page frequently for updates.

Last updated March 26, 2020

COVID-19 FUNDING OPPORTUNITIES
SPONSOR PROGRAM FUNDING DEADLINE
American Heart Association Rapid Response Grant COVIFD-19 and Its Cardiovascular Impact $100,000
(coordinating center $150,000)
4/6/2020
Centers for Disease Control (CDC)

 

Strengthening Public Health Systems & Services through National Partnerships to Improve & Protect the Nation's Health

$3,000,000

3/20/2020
(anticipated)

Applied Research Address the Coronavirus (COVID-19) Emerging Public Health Emergency

  3/25/2020
(call for white papers)

Department of Defense (DoD)

 

Request for Information for PPE in response to COVID-19

N/A 3/24/2020
(information accepted on a rolling basis)

Prototype Development to Combat Novel Coronavirus Disease COVID-19

TBD 4/15/2020
Department of Energy (DOE)

Soliciting input to COVID-19 response

DOE Resources Rolling
Medical CBRN Defense Consortium (MCDC)

 

 

Prototype Development to Combat Coronavirus (COVID-19)

undetermined pre-announcement

RFI CoV Pandemic Response

undetermined

3/19/2020-5/21/2020

(call for rapid response white papers)

Leveraging STRIDES for Cloud Computing Activities in Common Fund Awards (NOT-RM-20-009) Cloud Computing support >$10,000 beginning 4/1/2020
National Institutes of Health    Administrative Supplement NIAID no limit 2/6/2020
(applications accepted through 2/6/2021)
NOSI Regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025) not greater than parent award and reflective of actual need 3/5/2020
(applications accepted through 2/5/2021)
Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21) (PAR-18-781) $275,000 9/9/2020
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047) no limit 3/19/2020-3/31/2020
Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCOV)(NOT-AI-20-30) No limit 2/6/2021
(rolling basis)
NOSI: Availability of Administrative Supplements & Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757) not specified 3/17/2020 - 10/5/2020
(rolling basis)
Administrative Supplements to existing NIH Grants & Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) No limit Differs - check with Institutes/Centers
Partnerships for Countermeasures Against Select Pathogens (R01 Clinical Trials not Allowed) $3,750,000 6/29/2020
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) No limit 5/13/2020, 9/13/2020, see RFA for additional deadlines
 National Science Foundation (NSF)  RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 check with program officers for eligibility
Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)  $200,000 (RAPID) & supplemental funding requests check with program officers for eligibility
Office of Management & Budget (OMB) Administrative Relief for Recipients & Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (M-20-17) unspecified effective immediately
 Biomedical Advanced Research & Development Authority (BARDA)  BARDA Broad Agency Announcement negotiated after white paper submission  10/31/2020
White House Office of Science & Technology COVID-19 High Performance Computing Consortium (Xsede) Computing Resources effective immediately

Search Funding Institutional for more opportunities.